Avestar Capital, LLC Grifols Sa Transaction History

Avestar Capital, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 29, 2020	SELL	$18.24 - $21.45 $981,311 - $1.15 Million	-53,800 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$16.28 - $25.63 $875,864 - $1.38 Million	53,800 New	53,800 $1.08 Million
Q3 2019 Nov 14, 2019	SELL	$19.85 - $22.76 $61,515 - $70,533	-3,099 Closed	0 $0
Q2 2019 Aug 06, 2019	SELL	$17.59 - $21.1 $756 - $907	-43 Reduced 1.37%	3,099 $48,000
Q1 2019 May 09, 2019	BUY	$18.01 - $20.11 $5,006 - $5,590	278 Added 9.71%	3,142 $45,000

Q4 2018 Jan 25, 2019	SELL	$17.44 - $21.53 $16,916 - $20,884	-970 Reduced 25.3%	2,864 $33,000
Q3 2018 Oct 23, 2018	BUY	$19.97 - $21.96 $12,521 - $13,768	627 Added 19.55%	3,834 $63,000
Q2 2018 Aug 10, 2018	BUY	$20.16 - $24.68 $4,717 - $5,775	234 Added 7.87%	3,207 $51,000
Q1 2018 May 10, 2018	BUY	$20.31 - $24.95 $9,322 - $11,452	459 Added 18.26%	2,973 $46,000
Q4 2017 Feb 14, 2018	BUY	$20.99 - $23.89 $52,768 - $60,059	2,514	2,514 $46,000

150

140M

3.54M

919K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $4.51B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Avestar Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Avestar Capital, LLC with notifications on news.